Prescription Cream for Dermatitis
For adults with dermatitis (atopic dermatitis/eczema), topical corticosteroids are the first-line prescription treatment, with medium-potency steroids like triamcinolone or mometasone for body areas and low-potency hydrocortisone 1-2.5% for face and neck. 1, 2
Treatment Algorithm by Disease Severity and Location
First-Line: Topical Corticosteroids
Topical corticosteroids remain the mainstay of active dermatitis treatment with high certainty evidence supporting their use. 1, 2
- For facial and neck dermatitis: Use mild-potency corticosteroids (hydrocortisone 1-2.5%) once daily 2
- For body/trunk dermatitis: Use medium-potency corticosteroids (e.g., triamcinolone 0.1%, mometasone furoate) once to twice daily 1, 2
- For severe, refractory cases: Very high-potency corticosteroids (clobetasol propionate 0.05%) may be used for short courses only 2
- Duration: Continue until clear or almost clear, typically 2-6 weeks 2
Steroid-Sparing Alternatives: Topical Calcineurin Inhibitors
When corticosteroids are contraindicated or for sensitive areas prone to atrophy, tacrolimus and pimecrolimus are strongly recommended alternatives with high certainty evidence. 1
- Tacrolimus 0.1% ointment: Strongly recommended for adults with atopic dermatitis, particularly effective for facial eczema and sensitive areas 1, 2
- Pimecrolimus 1% cream: Strongly recommended for mild-to-moderate atopic dermatitis in adults 1
- FDA indication: Both are approved as second-line therapy for patients who have failed other topical treatments or when those treatments are not advisable 3
Important caveat: The FDA black box warning regarding cancer risk should be discussed with patients, though long-term safety studies suggest the absolute risk of lymphoma is low and likely not clinically meaningful 1
Newer Non-Steroidal Options
For patients seeking alternatives to both corticosteroids and calcineurin inhibitors:
- Ruxolitinib cream (JAK inhibitor): Strongly recommended with moderate certainty evidence for mild-to-moderate atopic dermatitis 1, 2
- Crisaborole ointment (PDE-4 inhibitor): Strongly recommended with high certainty evidence for mild-to-moderate atopic dermatitis 1, 2
Both provide anti-inflammatory effects without the atrophy risks of corticosteroids 2
Maintenance Therapy to Prevent Flares
Once acute dermatitis is controlled, intermittent proactive therapy prevents relapses with strong evidence. 1, 2
- Apply medium-potency topical corticosteroids twice weekly (e.g., weekend therapy) to previously affected areas even when skin appears clear 1, 2
- This maintenance approach significantly reduces disease flares and relapse 1
Essential Adjunctive Therapy: Emollients
All patients with dermatitis must use emollients as foundational therapy regardless of prescription treatment chosen. 1, 2
- Apply liberally and frequently (at least twice daily) with recommended usage of 200-400 grams per week 2
- Most effective when applied immediately after bathing 2
- Choose cream or ointment formulations over alcohol-containing lotions 2
Special Considerations
Elderly Patients with Pruritic Dermatitis
- Initially receive emollients and topical steroids for at least 2 weeks to exclude asteatotic eczema 1
- Moisturizers with high lipid content are preferred 1
- Avoid sedative antihistamines in elderly patients 1
Contact Dermatitis
- Topical corticosteroids combined with soap substitutes and emollients are the accepted treatment 1
- Long-term intermittent use of mometasone furoate has demonstrated efficacy in chronic hand eczema 1
Common Pitfalls to Avoid
- Do not use topical antihistamines for atopic dermatitis—they are conditionally recommended against 1
- Do not use topical antiseptics routinely (conditionally recommended against), except bleach baths may be considered for moderate-to-severe AD with clinical signs of secondary bacterial infection 1
- Do not use topical antimicrobials routinely for atopic dermatitis 1
- Avoid prolonged continuous use of high-potency corticosteroids due to atrophy risk; use intermittent maintenance therapy instead 1, 2